Assessment of Bacterial Loads of Essix Retainers in Patients Under Retention Therapy

December 18, 2021 updated by: Andrea Scribante, University of Pavia

A Protocol for the Assessment of the Bacterial Loads of Essix Retainers in Patients Under Retention Therapy: a Randomized Clinical Trial

The aim of this study is to investigate the bacterial loads present on essix retainers in patients' contention therapy. Patients are randomly divided into three groups, depending on the product used for the cleansing of the retainers: Geldis, Polident tablets and water. Microbiological samples were taken from the retainers at the baseline, after 1 and after 2 months, together with Bleeding Index, Plaque Index, BEWE Index and Schiff Air Sensitivity test.

Study Overview

Detailed Description

The aim of this study is to investigate the bacterial loads present on essix retainers in patients' contention therapy. Patients who wear essix retainers for contention therapy are randomly divided into three groups, depending on the product used for the cleansing of the retainers: Geldis, Polident tablets and water. Periodontal evaluation and microbiological samples are conducted at the baseline, after 1 and after 2 months.

Bacterial loads are collected from essix retainers, whereas Bleeding Index, Plaque Index, BEWE Index and Schiff Air Sensitivity test are assessed from the patients' mouth.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lombardy
      • Pavia, Lombardy, Italy, 27100
        • Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who completed orthodontic treatment and under Essix retainers phase.

Exclusion Criteria:

  • Patients under orthodontic treatment with fixed appliances or clear aligners.
  • Non-orthodontic patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Geldis® gel
Patients will brush their essix retainers with a toothbrush and with Geldis® gel.
Patients will clean their essix retainers with Geldis® using a toothbrush every night for 2 months.
Active Comparator: Tablets
Patients will leave their essix retainers in a glass with water and Polident tablets.
Patients will leave their essix retainers in a glass with water and Polident tablets every night for 2 months.
Active Comparator: Water
Patients will brush essix retainers with a toothbrush under running water.
Patients will brush their essix retainers with a toothbrush under water every night for 2 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in PCR% - Plaque Control Record (percentage)
Time Frame: Study begin, 1 and 2 months
% assessment of the amount of plaque on dental surfaces; it is detected on 4 surfaces: distal, mesial, vestibular, lingual / palatal. The number of sites with plaque is divided by the total number of sites available in the mouth and multiplied by 100. Results indicate the index as a percentage.
Study begin, 1 and 2 months
Change in BOP - Bleeding on Probing (percentage)
Time Frame: Study begin, 1 and 2 months

Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 4 sites (mesial, distal, vestibular, palatal/lingual).

Percentage of sites with bleeding on probing determines the BOP%.

Study begin, 1 and 2 months
Change in Schiff Air Index - Dental sensitivity test
Time Frame: Study begin, 1 and 2 months

Scoring criteria:

  • 0: the subject did not respond to air blasting;
  • 1: the subject responded to air blasting;
  • 2: the subject responded to air blasting and requested discontinuation;
  • 3: the subject responded to air blasting, requested discontinuation and considered the stimulus to be painful.
Study begin, 1 and 2 months
Change of the BEWE Index - Basic Erosive Wear Examination (Barlet et al., 2008)
Time Frame: Study begin, 1 and 2 months

Scoring criteria:

0: no erosive tooth wear;

  1. initial loss of surface texture;
  2. distinct defect, hard tissue loss < 50% of the surface area;
  3. hard tissue loss ≥ 50% of the surface area.
Study begin, 1 and 2 months
Change in microbiological loads of clear aligners
Time Frame: Study begin, 1 and 2 months

Microbiological assessment of the following loads:

  • Porphyromonas gingivalis
  • Tannarella forsythensis
  • Treponema denticola
  • Peptostreptococcus micros
  • Total bacterial load
Study begin, 1 and 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 12, 2021

Primary Completion (Actual)

December 15, 2021

Study Completion (Actual)

December 18, 2021

Study Registration Dates

First Submitted

April 27, 2021

First Submitted That Met QC Criteria

May 1, 2021

First Posted (Actual)

May 4, 2021

Study Record Updates

Last Update Posted (Actual)

December 21, 2021

Last Update Submitted That Met QC Criteria

December 18, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-ESSIX

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Data will be available upon motivated request to Principal Investigator

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthodontic Appliance Complication

Clinical Trials on Retainers' Cleansing with Geldis®

3
Subscribe